A relatively new therapeutic target in CLL is colony-stimulating factor 1R (CSF1R), expressed on tumor-associated macrophages (TAMs), and macrophage killing by CSF1R blockade induces CLL cell death, primarily through the tumor necrosis factor pathway128. Here, TNF is linked to B-cell chronic lymphocytic leukemia.